A research team at Academia Sinica has developed a key reagent for a pioneering rapid screening test for the COVID-19 coronavirus disease and the technology has been transferred to seven companies, one or two of which will be chosen for possible mass production, James Liao (廖俊智), president of Taiwan's most prestigious research institution, said Thursday.
(Full text of the story is now in CNA English news archive. To view the full story, you will need to be a subscribed member of the CNA archive. To subscribe, please read here.)
Latest
- Society
Flu season likely to happen earlier than usual: Taiwan CDC
09/16/2025 06:28 PM - Politics
Taiwan's updated civil defense guide focuses on wartime scenarios
09/16/2025 05:20 PM - Business
Taiwan shares close at new high as TSMC hits record
09/16/2025 05:20 PM - Science & Tech
MediaTek adopts TSMC's 2nm process for new flagship chip
09/16/2025 04:55 PM - Society
Danjiang Bridge sees last span being installed
09/16/2025 04:54 PM